Katalin Susztak highlights final 24 month NEJM data for iptacopan, framing complement inhibition as a major advance for IgA nephropathy treatment positioning.
Another win for nephrology ! Complement inhibitors in IgAN ! Iptacopan in IgA Nephropathy — Final 24-Month Data | @NEJM
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare